Sara L. Zettervall, MD

Assistant Professor
University of Washington
Seattle, Washington

Sara L. Zettervall MD, MPH is a board-certified surgeon at University of Washington Medical Center and an Assistant Professor of Surgery at University of Washington School of Medicine. She completed her general surgery training at George Washington University in Washington, DC followed by fellowship at Beth Israel Deaconess Medical Center in Boston. In addition, Dr. Zettervall completed a 2-year research fellowship at Harvard as part of the National Institute of Health Harvard-Longwood T32 Program. Her current research focuses on the evolving technology and treatment of aortic disease. She is an investigator in multiple clinical trials inclduing 2 physician sponsored investigational device exemption trials utilizing physician modified endografts as well as branched and fenestrated endografts for the treatment of juxtarenal and thoracoabdominal aneurysms.

Presentation(s):

• VESS03 - The Elevated Stroke/Death Rates among Asymptomatic Patients Undergoing Carotid Stenting in the Pacific Northwest Are Associated with High-Risk Patient Selection

  Wednesday, June 19, 2024
  1:46 PM – 1:55 PM CT

• Debate: Short Neck and Juxtarenal AAA: Is it Always a Clear Decision?: Short Neck and Juxtarenal Aortic Aneurysms: Custom Made F/BEVAR Gives Superior Outcome

  Thursday, June 20, 2024
  3:44 PM – 3:51 PM CT

• SS19 - F/BEVAR is increasing throughout the United States and associated with increased mortality when performed at hospitals without an investigational device exemption

  Friday, June 21, 2024
  10:24 AM – 10:35 AM CT

• RS24 - Utilization of percutaneous closure devices for large bore arterial access in genetic aortopathy patients does not result in increased rates of femoral cutdown or access site complications

  Saturday, June 22, 2024
  11:27 AM – 11:34 AM CT